Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
10/19/1989 | WO1989009601A2 Monosaccharides or polysaccharides used as antiviral agent |
10/19/1989 | WO1989009227A3 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis |
10/19/1989 | WO1989008657A3 Preparation of nitruro compounds usable as radio-pharmaceutical products |
10/18/1989 | EP0337589A2 Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines |
10/18/1989 | EP0337492A1 Purification of hepatitis proteins |
10/18/1989 | EP0337082A1 Immunoassay utilizing biotin bridge with universal solid phase |
10/18/1989 | CN1036326A Method and formulation for orally administering bioactive agents to and through the peyer's patch |
10/17/1989 | US4874708 Process for the preparation of intra-venously administered gamma-globulins and the gamma-globulins obtained |
10/17/1989 | US4874705 Immunizing chickens |
10/17/1989 | US4874702 Vectors and methods for making such vectors and for expressive cloned genes |
10/17/1989 | CA1262400A1 Process for the manufacture of glucosamine derivatives |
10/17/1989 | CA1262334A1 Steroidal liposomes |
10/17/1989 | CA1262333A1 Using monoclonal antibodies specific for treponema bacterial pathogens |
10/11/1989 | EP0336736A1 Purification of pertussis toxins and production of vaccine |
10/11/1989 | EP0336694A2 An anti-inflammatory factor from milk |
10/11/1989 | EP0336693A2 Acceleration of clot lysis |
10/11/1989 | EP0336678A2 Method for radiolabeling proteins |
10/11/1989 | EP0336677A1 A method for early detection of lung cancer |
10/11/1989 | EP0336631A2 Improved cytotoxic therapy |
10/11/1989 | EP0336562A1 Improvements relating to antigens |
10/11/1989 | EP0336405A2 Anti-human cancer protein complexes, their production and use |
10/11/1989 | EP0336379A2 Antibody heteroconjugates for use in regulation of lymphocyte activity |
10/10/1989 | US4873190 Heterodimeric T lymphocyte receptor |
10/10/1989 | US4873188 Method, monoclonal antibody, and monoclonal antibody fragments for detecting human non-small cell lung carcinomas and cell line for producing such antibodies |
10/10/1989 | US4873090 Comprising killed bacteria of hemophilus influenza. streptococcus pneumonia, pseudomonas aeruginosa or staphylococcus aureus; no adjuvants |
10/05/1989 | WO1989009405A1 Method for radiolabeling proteins |
10/05/1989 | WO1989009403A1 Diagnostic methods and systems for quantifying apo ai |
10/05/1989 | WO1989009286A1 PROTAMINE-REACTIVE IgM ANTIBODIES |
10/05/1989 | WO1989009271A1 Recombinant retroviruses |
10/05/1989 | WO1989009268A1 Production of insulin-like growth factor binding protein |
10/05/1989 | WO1989009260A1 Ryegrass pollen allergen |
10/05/1989 | WO1989009234A1 Therapeutic murine monoclonal antibody |
10/05/1989 | WO1989009233A1 Molecular sticks for controlling protein conformation |
10/05/1989 | WO1989009232A1 Neuropeptide antagonists |
10/05/1989 | WO1989009228A1 Peptides |
10/05/1989 | WO1989009227A2 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis |
10/05/1989 | WO1989009223A1 Dna binding proteins including androgen receptor |
10/05/1989 | WO1989009064A1 Synthetic peptides from streptococcal m protein and vaccines prepared therefrom |
10/05/1989 | WO1989009063A1 Novel non-reverting shigella live vaccines |
10/05/1989 | WO1989009061A1 Improved cytotoxic therapy |
10/04/1989 | EP0335635A1 Mutated HIV envelope protein |
10/04/1989 | EP0335550A1 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof |
10/04/1989 | EP0335476A2 Recombinant methods for the production of ricin a, ricin b, ricin or diphtheria toxin (dt)a or ab' fragment, suitable hosts and vectors therefor, and conjugates comprising ricin toxin a chain or diphtheria toxin |
10/04/1989 | EP0335135A2 Production of monoclonal antibodies specific for non-A, non-B hepatitis infected liver |
10/04/1989 | EP0334841A1 Micro-organisms and plasmids for producing 2,4-dichlorophenoxy acetic acid (2,4-d)-monooxygenase and process for producing these plasmids and strains. |
10/04/1989 | CN1036036A Cell-associated glucosyltransferase, antibody thereto, and dental caries prophylactic composition contg. said antibody as effective component |
10/03/1989 | US4871834 Anticarcinogenic agents, genetic engineering |
10/03/1989 | US4871824 Azlactone functional polymer beads |
10/03/1989 | US4871488 Extracting, mixing with phospholipid, deriving cochleate intermediate, contacting with calcium chelating agent |
10/03/1989 | CA1262093A1 Steroidal liposomes |
10/03/1989 | CA1262091A1 Influenza vaccine |
09/27/1989 | EP0334687A1 Immunoassays for incipient diabetes |
09/27/1989 | EP0334530A1 A recombinant marek's disease virus and a vaccine |
09/27/1989 | EP0334467A2 Cell-associated glucosyltransferase, an antibody thereto, and a dental caries prophylactic composition containing said antibody |
09/27/1989 | EP0334301A1 Recombinant retroviruses |
09/27/1989 | EP0334165A2 Monoclonal antibodies |
09/26/1989 | US4870161 Reagents and probes for distinguishing and isolating different GTP-binding proteins |
09/26/1989 | US4870053 Antiallergy acyl glycoprotein from klebsiella |
09/26/1989 | US4870026 Immunoassay |
09/26/1989 | US4870023 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
09/26/1989 | CA1262015A1 Acylated sugar derivatives, processes for their manufacture, and their use |
09/26/1989 | CA1261773A1 Non-a, non-b hepatitis assay and vaccine |
09/26/1989 | CA1261772A1 Equine influenza virus and its cultivation |
09/26/1989 | CA1261748A1 Method for treating intravenous immune globulin |
09/26/1989 | CA1261744A1 Ruthenium complexes |
09/26/1989 | CA1261742A1 Assay method employing fluorescent cell incorporative dye |
09/26/1989 | CA1261741A1 Fluorescent energy transfer with phycobiliproteins |
09/26/1989 | CA1261740A1 Immunoassay for detection of common determinant antibody to hepatitis b |
09/26/1989 | CA1261550A1 Chemically defined vaccine against urinary infections |
09/26/1989 | CA1261320A1 Modified meningococcal group b polysaccharide for conjugate vaccine |
09/26/1989 | CA1260827A1 Antibody-metal ion complexes |
09/26/1989 | CA1260392A1 Hepatitis a virus purified and triply cloned |
09/26/1989 | CA1260388A1 Method for diagnosing cancer |
09/26/1989 | CA1259934A1 Non-reverting salmonella live vaccines |
09/26/1989 | CA1259923A1 Physiologically active compositions |
09/26/1989 | CA1259922A1 Method for the isolation and purification of hepatitis b surface antigen |
09/26/1989 | CA1259921A1 Non-a non-b hepatitis antigens |
09/26/1989 | CA1259920A1 Immunotoxin and method of making |
09/26/1989 | CA1259917A1 Capsular polysaccharide metal complex vaccines |
09/26/1989 | CA1259911A1 Immunoassay or nucleic acid assay with gas phase detection of volatile tag |
09/21/1989 | WO1989008845A1 Antibodies, process for producing them, oligosaccharide haptens and clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
09/21/1989 | WO1989008843A1 Process for preparation of high molecular weight cell-associated protein of campylobacter pylori and use for serological detection of campylobacter pylori infection |
09/21/1989 | WO1989008711A1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
09/21/1989 | WO1989008709A1 Biologically active material characterised by catabolic activity generally associated with cachexia-inducing tumours, preparations, production and uses thereof |
09/21/1989 | WO1989008700A1 Diagnostic genes for toxoplasmosis |
09/21/1989 | WO1989008665A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO |
09/21/1989 | WO1989008664A1 Synthetic peptide antigens for the detection of htlv-1 infection |
09/21/1989 | WO1989008662A1 General cancer-associated scm-recognition factor, preparation and method of use |
09/21/1989 | WO1989008661A1 Human heat shock factor |
09/21/1989 | WO1989008657A2 Preparation of nitruro compounds usable as radio-pharmaceutical products |
09/21/1989 | WO1989008461A1 Interferon gamma composition to suppress immune system |
09/21/1989 | WO1989008460A1 Antibodies for use in antilymphocyte antibody therapy |
09/21/1989 | WO1989008458A1 Endocrine manipulation to improve body composition of poultry |
09/21/1989 | WO1989008449A1 Method of potentiating an immune response and composition therefor |
09/21/1989 | DE3807594A1 Antikoerper, verfahren zu ihrer herstellung, oligosaccharid-haptene und klone zur erzeugung der antikoerper sowie verwendung der antikoerper zur diagnose und therapie von tumoren Antibodies, methods for their manufacture, oligosaccharide haptens and clones for production of antibodies and use of antibodies for diagnosis and therapy of tumors |
09/20/1989 | EP0333606A2 Preparation of T-cell and T-cell membrane for use in prevention and treatment of autoimmune diseases |
09/20/1989 | EP0333523A2 Method of potentiating an immune response and compositions therefor |
09/20/1989 | EP0333444A2 Fast track method for producing monoclonal bi-specific immunoglobuline |
09/20/1989 | EP0333201A2 Human heat shock factor |
09/20/1989 | EP0333134A2 Gentechnological preparation of protein PP 15. |